Aiforia Technologies Plc, Company Release September 3, 2024 09:00 a.m. EEST

Change in Aiforia Technologies Plc’s Management Team

Aiforia Technologies Plc reinforces its Management Team to strengthen the implementation of the company’s growth strategy. Tamas Regenyi (Master of Science, Economy) has been appointed Chief Commercial Officer and a member of the Management Team as of September 3, 2024. Tamas joined Aiforia in May 2022 and since then he has held the position of Vice President, Sales EMEA and APAC.

Tamas has more than 20 years of experience from various global executive positions in sales management and business development. In addition, he has more than 10 years of experience in the field of digital pathology and medical diagnostics market. Prior to Aiforia, he held various commercial and sales management positions at 3DHISTECH, Ericsson and Cisco.

"We are strengthening Aiforia’s management team to bring European commercial operations and market intelligence more closely into strategic decision-making. Tamas has extensive experience and knowledge in the digital pathology field, and together with his team, he has had a pivotal role in developing Aiforia’s business strategy in Europe as well as advancing Aiforia’s position in the clinical diagnostics market for pathology. In addition, Tamas has been instrumental in securing recently announced key customer wins," says Jukka Tapaninen, CEO of Aiforia.

After the appointment, the composition of Aiforia’s Management Team is as follows:

Jukka Tapaninen, Chief Executive Officer

Kaisa Helminen, Chief Operating Officer

Tuomas Ropponen, Chief Technology Officer

Veli-Matti Parkkonen, Chief Financial Officer

Thomas Westerling-Bui, Chief Commercial Officer, Americas

Panu Kauppila, Chief Product Officer

Tamas Regenyi, Chief Commercial Officer

More detailed information on the members of the Management Team are available on the company's website at https://investors.aiforia.com/en/investors/corporate_governance/management_team.

Further inquiries 

Jukka Tapaninen, CEO, Aiforia Technologies Plc

tel. +33 61 041 6686

https://investors.aiforia.com/

Certified Adviser

UB Corporate Finance Ltd

ubcf@unitedbankers.fi

About Aiforia 

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com